VAM
BIOL

Visium Asset Management’s Biolase, Inc. BIOL Stock Holding History

Visium Asset Management’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-141
Closed -$1.58M – 895
2015
Q3 		$1.58M Hold
141
– – 0.02% 469
2015
Q2 		$3.07M Buy
141
+21
+18% +$512K 0.04% 367
2015
Q1 		$3.03M Buy
+120
New +$3.4M 0.04% 353

Other funds holding BIOL

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
PCMI
Princeton Capital Management Inc Princeton, New Jersey $198M AUM 28.98% 1-Year Est. Return
TA
Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Visium Asset Management's BIOL Position: Q4 2015 in Review

Visium Asset Management sold out of Biolase, Inc. (BIOL) in Q4 2015, closing a stake of 141 shares — an estimated $1.58M sold.

Visium Asset Management first reported a position in BIOL in Q1 2015 and held it in 3 quarters. The position peaked at $3.07M in Q2 2015. 30 funds tracked by Wall St. Rank hold BIOL as of Q4 2015.

  • Visium Asset Management reported no remaining Biolase, Inc. position as of Q4 2015 after selling out during the quarter.
  • Visium Asset Management sold 141 Biolase, Inc. shares in Q4 2015, an estimated $1.58M.
  • Visium Asset Management first reported a position in Biolase, Inc. in Q1 2015 and held it in 3 quarters.
  • Visium Asset Management's Biolase, Inc. position peaked at $3.07M in Q2 2015.
  • 30 funds tracked by Wall St. Rank held Biolase, Inc. as of Q4 2015.

Based on Visium Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.